Key result
Fontan circuit stenting is associated with a ~32% PVR decrease, greater than inspired nitric oxide.
Why the study?
The effect of relief of obstruction within the Fontan circuit on pulmonary vascular resistance has not been quantified.
Does stenting of Fontan circuit obstructions reduce pulmonary vascular resistance more than inspired nitric oxide in post-Fontan patients?
Observational (n=12)
No
Does stenting of Fontan circuit obstructions reduce pulmonary vascular resistance more than inspired nitric oxide in post-Fontan patients?
Absolute Event Rate: 32.1% vs 19.3%
p-value: p=.03
Stenting of Fontan circuit obstructions significantly reduces pulmonary vascular resistance, providing a quantifiable hemodynamic mechanism for symptomatic improvement in single-ventricle patients.
May support stenting in select Fontan cases; hypothesis-generating and should not yet change practice.
OBJECTIVES: Patients with single-ventricle congenital heart disease undergo staged surgical palliations leading to a final Fontan procedure. After Fontan, cardiac index (CI) is primarily determined by pulmonary vascular resistance (PVR). Lower Fontan pressure has been achieved after relieving obstruction within the Fontan circuit, but to date the effect on PVR has not been quantified. We hypothesized that there would be significant reduction in PVR after relief of obstruction within the Fontan circuit; the purpose of this study is therefore to describe the change in PVR after relief of Fontan obstruction. METHODS: Retrospective, single-center review of post-Fontan patients who underwent cardiac catheterization with hemodynamics, pulmonary vasodilator testing, and stenting of Fontan circuit obstructions from October 2016 to August 2019. Baseline hemodynamics were obtained on 21% fraction of inspired oxygen (FiO2), followed by administration of 80 ppm inspired nitric oxide (iNO) with repeat hemodynamics. After stenting of Fontan obstructions, hemodynamics were repeated on 21% FiO2. Patient demographics, hemodynamics, CI, and PVR were compared. RESULTS: Twelve patients underwent stenting of Fontan circuit obstructions. There was complete relief of gradient and angiographic obstruction after stent placement in all patients. There was larger decrease in PVR after stent placement compared with iNO administration (32.1% vs 19.3%, respectively; P=.03). CONCLUSIONS: This case series provides novel data quantifying the decrease in PVR after relief of Fontan circuit obstruction, suggesting a mechanism for symptomatic improvement after intervention. These data are a compelling addition to the longterm management of this complex patient population.
No takes yet. Share an insight, caveat, or question.
Yell et al. (2020) conducted an observational in Single-ventricle congenital heart disease with Fontan circuit obstruction (n=12). Stenting of Fontan circuit obstructions vs. Inspired nitric oxide (iNO) administration was evaluated on Decrease in pulmonary vascular resistance (PVR) (p=.03). Stenting of Fontan circuit obstructions resulted in a significantly larger decrease in pulmonary vascular resistance compared with inspired nitric oxide administration (32.1% vs 19.3%; P=.03).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: